Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 283.83M | 283.83M | 292.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 283.83M | 283.83M | 292.08M |
| Cost of Revenue | -- | -- | 165.32M | 166.00M | 165.45M |
| Gross Profit | -- | -- | 118.51M | 117.83M | 126.63M |
| SG&A Expenses | -- | -- | 116.44M | 115.77M | 106.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 656.00K | 656.00K | 2.72M |
| Total Operating Expenses | -- | -- | 282.42M | 282.42M | 274.32M |
| Operating Income | -- | -- | 1.41M | 1.41M | 17.76M |
| Income Before Tax | -- | -- | -112.65M | -112.65M | -49.54M |
| Income Tax Expenses | -- | -- | -15.82M | -15.82M | -6.70M |
| Earnings from Continuing Operations | -- | -- | -96.83 | -96.83 | -42.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 23.94M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -96.83M | -96.83M | -19.13M |
| EBIT | -- | -- | 1.41M | 1.41M | 17.76M |
| EBITDA | -- | -- | 13.56M | 13.52M | 30.30M |
| EPS Basic | -- | -- | -0.19 | -0.19 | -0.03 |
| Normalized Basic EPS | -- | -- | -0.17 | -0.17 | -0.11 |
| EPS Diluted | -- | -- | -0.20 | -0.20 | -0.03 |
| Normalized Diluted EPS | -- | -- | -0.17 | -0.17 | -0.11 |
| Average Basic Shares Outstanding | -- | -- | 1.95B | 1.95B | 1.92B |
| Average Diluted Shares Outstanding | -- | -- | 1.95B | 1.95B | 1.92B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -0.89% |